[1]
F. Z. El Sewy, M. Megalaa, N. Michael, and N. Tadros, “Study of the Association between Plasminogen Activator Inhibitor-1, other Inflammatory Markers, Metabolic Control Parameters, and Diabetic Foot Disease”, BMRAT, vol. 9, no. 3, pp. 4986-4995, Mar. 2022.